China is evolving from a manufacturing base into a globally competitive engine for drug innovation, driven by scale, speed, and integration into pharmaceutical value chains.
Structural advantages such as rapid clinical development, cost efficiency, and manufacturing scale are accelerating both innovation and global market share gains.
A “develop locally, monetize globally” model—supported by rising licensing activity and process leadership—is positioning China as a central player in global healthcare.
Yau Ming Low/iStock via Getty Images
China is no longer just a low-cost manufacturing hub - it has become a global engine of healthcare innovation. Across drug discovery, development, and commercialization, the country’s scale, speed, and integration into global pharmaceutical value chains have reshaped its role. To understand
